XML 69 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Tables)
3 Months Ended 9 Months Ended
Sep. 29, 2013
Sep. 29, 2013
Fair Value Disclosures [Abstract]    
Summary of designated derivatives
The following table is a summary of the activity related to derivatives designated as hedges for the fiscal third quarters in 2013 and 2012:
 
 
 
 
 
 
 
 
 
 
 
Gain/(Loss)
Recognized in
Accumulated
OCI(1)
 
Gain/(Loss) Reclassified from
Accumulated OCI
into Income(1)
 
Gain/(Loss)
Recognized in
Other
Income/Expense(2)
 
 
Fiscal Third Quarters Ended
Cash Flow Hedges by Income Statement Caption
 
September 29, 2013
 
September 30, 2012
 
September 29, 2013
 
September 30, 2012
 
September 29, 2013
 
September 30, 2012
(Dollars in Millions)
 
 
 
 
 
 
 
 
 
 
 
 
Sales to customers(3)
 
$
25

 
30

 
17

 
(12
)
 

 
(1
)
Cost of products sold(3)
 
42

 
(61
)
 
51

 
(19
)
 

 
(1
)
Research and development expense(3)
 
(20
)
 
22

 
(14
)
 
43

 

 

Interest (income)/Interest expense, net(4)
 
7

 
28

 
(2
)
 
(2
)
 

 

Other (income)expense, net(3)
 
(13
)
 
(24
)
 
(8
)
 
19

 

 
1

Total
 
$
41

 
(5
)
 
44

 
29

 

 
(1
)
The following table is a summary of the activity related to derivatives designated as hedges for the fiscal nine months in 2013 and 2012:
 
 
 
 
 
 
 
 
 
 
 
Gain/(Loss)
Recognized in
Accumulated
OCI(1)
 
Gain/(Loss) Reclassified from
Accumulated OCI
into Income(1)
 
Gain/(Loss)
Recognized in
Other
Income/Expense(2)
 
 
Fiscal Nine Months Ended
Cash Flow Hedges by Income Statement Caption
 
September 29, 2013
 
September 30, 2012
 
September 29, 2013
 
September 30, 2012
 
September 29, 2013
 
September 30, 2012
(Dollars in Millions)
 
 
 
 
 
 
 
 
 
 
 
 
Sales to customers(3)
 
$
22

 
16

 
24

 
(42
)
 

 
(1
)
Cost of products sold(3)
 
220

 
(100
)
 
72

 
(53
)
 
4

 
(1
)
Research and development expense(3)
 
(27
)
 
33

 
(31
)
 
56

 
(3
)
 

Interest (income)/Interest expense, net(4)
 
15

 
(14
)
 
(6
)
 
(11
)
 

 

Other (income)expense, net(3)
 
(6
)
 
(25
)
 
(6
)
 
27

 
(1
)
 

Total
 
$
224

 
(90
)
 
53

 
(23
)
 

 
(2
)
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial assets and liabilities at fair value  
The Company’s significant financial assets and liabilities measured at fair value as of September 29, 2013 and December 30, 2012 were as follows:
 
 
September 29, 2013
 
 
 
December 30, 2012
(Dollars in Millions)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Total(2)
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$

 
482

 

 
482

 
423

Cross currency interest rate swaps(3)
 

 
127

 

 
127

 
98

Total
 

 
609

 

 
609

 
521

Liabilities:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 

 
181

 

 
181

 
252

Cross currency interest rate swaps(4)
 

 
10

 

 
10

 
10

Total
 

 
191

 

 
191

 
262

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 

 
37

 

 
37

 
75

Liabilities:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 

 
15

 

 
15

 
23

Other Investments(1)
 
$
405

 

 

 
405

 
1,247


(1)
Classified as non-current other assets. The change in the fair value from December 30, 2012 was primarily due to the sale of Elan American Depositary Shares.
(2)
As of December 30, 2012, these assets and liabilities are classified as Level 2 with the exception of Other Investments of $1,247 million which are classified as Level 1.
(3)
Includes $127 million and $96 million of non-current assets for September 29, 2013 and December 30, 2012, respectively.
(4)
Includes $5 million and $4 million of non-current liabilities for September 29, 2013 and December 30, 2012, respectively.
Financial assets and liabilities not measured at fair value  
Financial Instruments not measured at Fair Value:

The following financial assets and liabilities are held at carrying amount on the consolidated balance sheet as of September 29, 2013:
(Dollars in Millions)
 
Carrying Amount

 
Estimated Fair Value

Financial Assets
 
 
 
 
Current Investments
 
 
 
 
Cash
 
$
2,701

 
2,701

Government securities and obligations
 
19,884

 
19,884

Corporate debt securities
 
611

 
611

Money market funds
 
1,399

 
1,399

Time deposits
 
633

 
633

Total cash, cash equivalents and current marketable securities
 
$
25,228

 
25,228

 
 
 
 
 
Fair value of government securities and obligations and corporate debt securities was estimated using quoted broker prices and significant other observable inputs.
Financial Liabilities
 
 
 
 
 
 
 
 
 
Current Debt
 
$
5,359

 
5,359

Non-Current Debt
 
 
 
 
2.15% Notes due 2016
 
898

 
932

5.55% Debentures due 2017
 
1,000

 
1,159

5.15% Debentures due 2018
 
898

 
1,041

4.75% Notes due 2019 (1B Euro 1.3503)
 
1,345

 
1,605

3% Zero Coupon Convertible Subordinated Debentures due in 2020
 
178

 
260

2.95% Debentures due 2020
 
542

 
564

3.55% Notes due 2021
 
446

 
470

6.73% Debentures due 2023
 
250

 
323

5.50% Notes due 2024 (500 GBP 1.6042)
 
797

 
965

6.95% Notes due 2029
 
296

 
404

4.95% Debentures due 2033
 
500

 
561

5.95% Notes due 2037
 
995

 
1,226

5.85% Debentures due 2038
 
700

 
832

4.50% Debentures due 2040
 
539

 
556

4.85% Notes due 2041
 
298

 
322

Other
 
66

 
66

Total Non-Current Debt
 
$
9,748

 
11,286



The weighted average effective interest rate on non-current debt is 5.12%.

Fair value of the non-current debt was estimated using market prices, which were corroborated by quoted broker prices and significant other observable inputs.